[{"NetIncomeLoss_3_Q3_USD":-46703000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":11184000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4065000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":72342070.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":79487444.0,"TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_1_Q3_USD":44000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-48127000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":35067000.0,"Depreciation_3_Q3_USD":1491000.0,"Depreciation_1_Q3_USD":490000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":48760000.0,"ProceedsFromAccountsReceivableSecuritization_3_Q3_USD":0.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":1164000.0,"GoodwillImpairmentLoss_1_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":121242000.0,"RestructuringCharges_3_Q3_USD":64000.0,"RestructuringCharges_1_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":31600000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":336000.0,"CommonStockSharesIssued_0_Q3_shares":84618575.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":21400000.0,"Assets_0_Q3_USD":131104000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-72000.0,"ShareBasedCompensation_3_Q3_USD":4730000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2491000.0,"LegalFees_3_Q3_USD":0.0,"LegalFees_1_Q3_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":6913000.0,"EquityMethodInvestments_0_Q3_USD":0.0,"Liabilities_0_Q3_USD":33759000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2733000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":32946000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":12065000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-56000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1075000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"NumberOfReportableSegments_3_Q3_numberOfSegments":1.0,"CommonStockValue_0_Q3_USD":965369000.0,"Revenues_1_Q3_USD":1523000.0,"Revenues_3_Q3_USD":4528000.0,"EmployeeStockOwnershipPlanESOPCompensationExpense_3_Q3_USD":100000.0,"EmployeeStockOwnershipPlanESOPCompensationExpense_1_Q3_USD":100000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-147000.0,"PaymentsToAcquireOtherInvestments_3_Q3_USD":28904000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1491000.0,"EmployeeBenefitsAndShareBasedCompensation_3_Q3_USD":300000.0,"EmployeeBenefitsAndShareBasedCompensation_1_Q3_USD":300000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-84000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-19000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":-56000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":66536000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":348000.0,"EmployeeStockOwnershipPlanESOPSharesInESOP_0_Q3_shares":1500000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-55703000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-21782000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-46601000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-18783000.0,"OtherAssetsNoncurrent_0_Q3_USD":109000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":96918000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":66120000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":447000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_3_Q3_USD":58000.0,"PreferredStockAccretionOfRedemptionDiscount_1_Q3_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-2545000.0,"PreferredStockDividendsAndOtherAdjustments_3_Q3_USD":9000000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q3_USD":3027000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":7133000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-46703000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-18755000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1658000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-36428000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_3_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":7608000.0,"RestructuringReserveAccrualAdjustment1_3_Q3_USD":-137000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-2545000.0,"NonoperatingIncomeExpense_3_Q3_USD":-5198000.0,"InterestExpense_3_Q3_USD":3214000.0,"InterestExpense_1_Q3_USD":1074000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":96918000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1871000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":416000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":51000.0,"PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_0_Q3_USD":146285000.0,"AdditionalPaidInCapital_0_Q3_USD":59614000.0,"IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_3_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":1164000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":3301000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":7262000.0,"NetIncomeLoss_1_Q3_USD":-18755000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3538000.0,"DividendsPreferredStockCash_3_Q3_USD":9000000.0,"CommonStockSharesOutstanding_0_Q3_shares":84618575.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-129000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-350000.0,"OperatingIncomeLoss_3_Q3_USD":-41505000.0,"OperatingIncomeLoss_1_Q3_USD":-15217000.0,"AccountsPayableTradeCurrent_0_Q3_USD":852000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":21378000.0,"RestructuringReserve_0_Q3_USD":0.0,"InvestmentIncomeInterest_3_Q3_USD":645000.0,"InvestmentIncomeInterest_1_Q3_USD":100000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.21,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q3_USD":2.25,"LiabilitiesAndStockholdersEquity_0_Q3_USD":131104000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4730000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1688000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":378000.0,"OperatingExpenses_3_Q3_USD":46033000.0,"OperatingExpenses_1_Q3_USD":16740000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.77,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.27,"StockholdersEquity_0_Q3_USD":97345000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":77000.0,"ProceedsFromSaleOfRestrictedInvestments_3_Q3_USD":66548000.0,"LossContingencyEstimateOfPossibleLoss_0_Q3_USD":400000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-71000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-285000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_3_Q3_USD":44000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":44000.0,"PaymentsForAdvanceToAffiliate_3_Q3_USD":2500000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1025796000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":65119000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q3_USD":-72000.0,"GainLossOnSaleOfEquityInvestments_3_Q3_USD":-2544000.0,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]